Global Recombinant Brazzein Market Strategic Research Report

Scope of the Report

The global Recombinant Brazzein market size is predicted to grow from US$ 177 million in 2025 to US$ 308 million in 2032; it is expected to grow at a CAGR of 8.2% from 2026 to 2032.

Brazzein, a naturally derived sweet protein, was first isolated from the fruit of the tropical West African plant *Pentadiplandra brazzeana*. Its sweetness is 500 to 2,000 times that of sucrose, making it one of the most potent natural sweet proteins known. Through modern recombinant DNA technology, it can be expressed and produced in microorganisms or engineered bacteria (such as yeast and bacteria), giving this high-sweetness protein the potential for large-scale commercialization. Compared to traditional artificial sweeteners, Brazzein, a protein-based sweetener, is low in calories, thermally stable, pH stable, non-bitter, and readily water-soluble. It maintains its sweetness during food processing, providing a natural sweetening solution for low-sugar or sugar-free foods. With a molecular weight of approximately 6.5 kDa, its extremely high sweetness intensity, and taste close to sucrose, makes it a promising alternative sweetener in the food industry, particularly in beverages, confectionery, pastries, and nutritional foods. In 2024, global production of Recombinant Brazzein reached 403.11 tons, with an average selling price of $450/kg. Production volume is significantly lower than traditional sweeteners and is primarily driven by a few synthetic biotechnology companies, with a gross profit margin of approximately 35%–55%.

Currently, the strains used for research and production of brassin mainly include: *E. coli*, yeast, *Pichia pastoris*, *Aspergillus oryzae* host expression, and recombinant *Trichoderma reesei* strains. The challenges to its industrialization lie in the problems of current microbial expression systems (such as *E. coli* and fungi), such as low protein expression levels, protein misfolding leading to reduced activity, and complex and costly purification processes. All of these factors limit the widespread application of sweet proteins. Key advancements in the development of brazzein in the industry include:

In May 2023, California-based food ingredient startup Sweeten successfully produced the super-sweet protein Brazzein using precision fermentation technology, becoming the first company to receive FEMA GRAS (Generally Recognized As Safe, GRAS) certification.

In 2024, Oobli, a US-based company, successfully obtained FDA GRAS certification for its brazzein produced using precision fermentation technology, allowing it to be used in food and beverages. In February 2025, Oobli announced a collaboration with sweetener giant Ingredion to advance the sweetener applications of brazzein.

In May 2024, synthetic biology leader Ginkgo Bioworks partnered with GreenLab to work on improving the expression of brazzein in corn kernels and utilizing precision fermentation technology to achieve commercial-scale production of brazzein.

In March 2025, Waterdrop Agriculture also received FDA SELF-GRAS certification, becoming one of the few companies globally to achieve commercialization. And we are selling to countries and regions that accept this certification. Currently, we are promoting our products in the United States, Latin America, and Southeast Asia.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Recombinant Brazzein market?

What factors are driving Recombinant Brazzein market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Recombinant Brazzein market opportunities vary by end market size?

How does Recombinant Brazzein break out by Type, by Application?

This report presents a comprehensive overview of the global Recombinant Brazzein market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Purity 90%-95%
• Purity greater than 95%

Segment by Channel

• Commercial Use
• Home Use

Segment by Sales

• Direct Selling
• Distribution

Segment by Application

• Dairy Products
• Baking
• Dietary Supplements
• Beverages
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Recombinant Brazzein market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Dairy Products, Baking, Dietary Supplements evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact